桡动脉痉挛(RAS)是经桡动脉进入部位交叉的最常见原因,是一种常见的术中并发症。RAS发生率可导致术后桡动脉闭塞(RAO),防止桡动脉作为未来的进入部位。我们评估了硝酸甘油在经桡动脉导管插入术中预防RAS和RAO的疗效,讨论了不同的给药途径。包括局部的,皮下,和动脉内。系统评价和荟萃分析包括所有相关文章,直到2022年4月23日。我们搜索了谷歌学者的六个数据库,WebofScience,Scopus,EMBASE,PubMed(MEDLINE),中央。我们在PROSPERO注册了我们的审查方案,ID:CRD4202230356。我们纳入了11项试验,共5814例患者。与安慰剂相比,汇总分析支持皮下注射硝酸甘油预防RAS(风险比[RR]:0.57,95%置信区间[CI][0.43-0.77],p=.0003)和RAO(RR:0.39,95%CI[0.16-0.98],p=.05)。与动脉内硝酸甘油在预防RAS和RAO方面显示无统计学意义的结果相反(RR:0.8,95%CI[0.63-1.02],p=.07)-(RR:0.78,95%CI[0.6-1.01],p=.06)),分别。此外,局部硝酸甘油不能预防RAS(RR:0.73,95%CI[0.42-1.24],p=.24)。与安慰剂相比,经桡动脉插管期间皮下硝酸甘油降低了RAS和RAO的发生率。同时,动脉内和局部硝酸甘油没有显示统计学意义的结果。皮下硝酸甘油可能是一种实用且具有成本效益的技术,可以促进经桡动脉插管;然而,需要更多的RCT来评估皮下和动脉内硝酸甘油给药.
Radial artery spasm (RAS) is the most common cause of transradial access site crossover and is a common intra-procedural complication. RAS incidence can lead to radial artery occlusion (
RAO) postprocedure, preventing the radial artery as a future access site. We evaluated the efficacy of nitroglycerin preventing RAS and
RAO during transradial catheterization discussing the different routes of administration, including topical, subcutaneous, and intra-arterial. A systematic review and meta-analysis included all relevant articles until April 23, 2022. We searched six databases Google Scholar, Web of Science, SCOPUS, EMBASE, PubMed (MEDLINE), and CENTRAL. We registered our review protocol in PROSPERO with ID: CRD42022330356. We included 11 trials with 5814 patients. Compared to placebo, the pooled analysis favored subcutaneous nitroglycerin in preventing RAS (risk ratio [RR]: 0.57 with 95% confidence interval [CI] [0.43-0.77], p = .0003) and
RAO (RR: 0.39 with 95% CI [0.16-0.98], p = .05). In contrast to the intra-arterial nitroglycerin that showed nonstatistically significant results in preventing RAS and
RAO (RR: 0.8 with 95% CI [0.63-1.02], p = .07)- (RR: 0.78 with 95% CI [0.6-1.01], p = .06)), respectively. Also, topical nitroglycerin did not prevent RAS (RR: 0.73 with 95% CI [0.42-1.24], p = .24). Compared with placebo, subcutaneous nitroglycerin during transradial catheterization reduced the incidence of RAS and
RAO. Meanwhile, Intra-arterial and topical nitroglycerin did not show statistically significant outcomes. Subcutaneous nitroglycerin may be a practical and cost-effective technique to facilitate transradial catheterization; however, more RCTs are needed to evaluate the subcutaneous versus intra-arterial nitroglycerin administration.